United States influenza vaccines market is projected to grow with a significant CAGR in the forecast

DELHI, India - April 29, 2021 - PRLog -- The number of persons being vaccinated with influenza vaccines worldwide will touch the figure of 500 Million by the year-end of 2027.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccines, the introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most of the countries.

Long–term Growth Projection:

• The global influenza vaccines market size is set to surpass US$ 6.5 Billion by the year-end of 2021
• Influenza vaccines demand is expected to increase in the forecast period
• The United States influenza vaccines market is projected to grow with a significant CAGR in the forecast period
• In Japan, the influenza vaccines market holds a rewarding growth opportunity for the future as the demand for the vaccine is growing significantly
• The Chinese influenza vaccines market is expected to record a value of nearly US$ 180 Million by the year-end of 2027
• Europe is anticipated to be the fastest-growing market during the forecast period
• The United Kingdom and Germany are the leading revenue generators of the market
• Emerging players backed by technological advancements are developing vaccines that offer a more realistic experience

Key Features of the Study:

• The Market Size of the Global Influenza Vaccines Market with Six Years Forecast
• The Market Size of the Regional and National Influenza Vaccines Market with Six Years Forecast
• Scrutinizes the Global Overall Persons Being Vaccinated with Influenza Vaccines
• Scrutinizes the Regional and National Persons Being Vaccinated with Influenza Vaccines
• Delivers a Latest Happenings in the Global Influenza Vaccines Market
• Detailed Insights of the Regulatory Framework Including the Approval Process and an Overview of the Regulatory Authorities in the United States, EU, and Japan
• Provides Key Trends with Respect to Collaboration Deals, Merger & Acquisitions, Distribution, Exclusive and Licensing Agreement
• Reviews Most Recent Clinical Trials of the Influenza Vaccines
• A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development
• An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development

More Information about this report: https://dpiresearch.com/reports/global-influenza-vaccines...